Friday, July 20, 2018 4:34:40 PM
I've seen Roche buy into Genentech, then buy them out, then spin them out, then buy them out again. The point is that big Pharma has frequently partnered with companies, often taking a substantial interest with the purchase of say 20 to 40% of the stock, this by itself gives them a major say as to how the company functions. In a voting situation, it's almost impossible to defeat a measure supported by someone controlling 30% of the stock.
Either drug in trials today could bring such a partnership, together they'd bring more. The question is, how much would it take, and that's where I believe we'd be talking billions, immediately giving the company a multi-billion dollar market cap. I don't know if, or when such action may occur, but I don't think you can deny the possibility of it happening, and if you cannot do that, you cannot deny the possibility of a multi-billion dollar market cap in the near term future.
Gary
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM